In in vitro investigations, it was shown that IGF1 stimulates DNA synthesis, cyclin D1 expression and the inhibition of proteasome-mediated cathepsin B (CTSB) degradation, which leads to HCC progression and metastasis. This evidence concerns the gene IGF1 and hepatocellular carcinoma.